Asieris Included in the SSE STAR Biology and Medicine Index

August 30, 2022

Highlights of Asieris 2022 Semi-Annual Report

August 25, 2022

Asieris Pharmaceuticals (688176.SH) Issued 2022 Semi-Annual Report: Accelerated Global Clinical Development and Progressive Implementation of Its Integrated Diagnosis-Treatment Commercialization Strategy

August 25, 2022

Now Hiring: Business Development Director (Remote)

August 11, 2022

Now Hiring: Biomarker Scientist (Onsite, Mountain View)

August 11, 2022

Now Hiring: Protein Scientist (Onsite, Mountain View)

August 11, 2022

Now Hiring: Bioinformatics Scientist (Onsite, Mountain View)

August 11, 2022

Now Hiring: Research Associate or Sr. RA (Onsite, Mountain View)

August 11, 2022

Asieris Appoints Dr. Badrinath Konety to Scientific Advisory Board

August 10, 2022